GB0710059D0
|
|
New morphology of pharmaceutical crystalline form
|
GB0705264D0
|
|
Gel forming compounds
|
GB0703328D0
|
|
Gel forming compounds
|
GB0702826D0
|
|
Preparation and composition of solid dosage form containing Bicalutamide
|
GB0623897D0
|
|
Pharmaceutical composition of memantine
|
GB0621623D0
|
|
Pharmaceutical compositions
|
GB0619983D0
|
|
Pregabalin formulation
|
GB0619891D0
|
|
Pharmaceutical composition of risedronate
|
GB0619888D0
|
|
New polymorphic forms of pregabalin
|
GB0614485D0
|
|
Process
|
GB0614133D0
|
|
Process for preparing a pharmaceutical compound
|
GB0613927D0
|
|
Pharmaceutically acceptable salt and polymorphic forms
|
GB0613928D0
|
|
Pharmaceutically acceptable salt and polymorphic forms
|
GB0613826D0
|
|
Process and product
|
GB0610570D0
|
|
Novel formulation
|
GB0610207D0
|
|
New forms of active pharmaceutical ingredient
|
GB0609835D0
|
|
Impurities of a pharmaceutical product
|
GB0606234D0
|
|
Pharmaceutically acceptable salts and polymorphic forms
|
GB0605344D0
|
|
Pharmaceutically acceptable salts and polymorphic forms
|
WO2006051340A1
|
|
Novel form of celecoxib
|